NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced on Wednesday that it has received a medical device license from Canadian regulators for its NGSengine human leukocyte antigen (HLA) typing software.
NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced on Wednesday that it has received a medical device license from Canadian regulators for its NGSengine human leukocyte antigen (HLA) typing software.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.